Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire.

Autor: Oort Q; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Centers (Location VUmc), Amsterdam, the Netherlands., Reijneveld JC; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Centers (Location VUmc), Amsterdam, the Netherlands; Department of Neurology, Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands., Sikkes SAM; Alzheimer Center, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands; Vrije Universiteit Amsterdam, Faculty of Behavioural and Movement Sciences (FGB), Department of Clinical Developmental & Clinical Neuropsychology, Amsterdam, the Netherlands., Koekkoek JAF; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands., Boele F; Leeds Institute of Medical Research, St James's University Hospital, Leeds LS9 7TF, United Kingdom; Leeds Institute of Health Sciences, Faculty of Medicine and Health, University of Leeds, Leeds LS2 9JT, United Kingdom., Young T; East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, United Kingdom., Brannan C; East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, United Kingdom., Chalk T; East & North Hertfordshire NHS Trust Incorporating Mount Vernon Cancer Centre, Northwood, United Kingdom., Talacchi A; Department of Neurosurgery, Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy., Mazzotta A; Department of Neurosurgery, Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy., Narita Y; Department of Neurosurgery and Neuro-oncology, National Cancer Center Hospital, Tokyo, Japan., Sato H; Department of Neurosurgery and Neuro-oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Nursing, Teikyo Heisei University, Tokyo, Japan., Miyakita Y; Department of Neurosurgery and Neuro-oncology, National Cancer Center Hospital, Tokyo, Japan; Cancer Institute Hospital of JFCR, Tokyo, Japan., Shamieh O; Department of Palliative Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan; School of Medicine, University of Jordan, Amman, Jordan; Center for Palliative & Cancer Care in Conflict (CPCCC), KHCC, Amman, Jordan., Alrjoob W; Center for Palliative & Cancer Care in Conflict (CPCCC), KHCC, Amman, Jordan., Pace A; Neuro-Oncology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Petranovic D; Department of Hematology, Clinical Hospital Center Rijeka, Rijeka, Croatia., Ploh M; Department of Hematology, Clinical Hospital Center Rijeka, Rijeka, Croatia., Capela A; Associação de Investigação de Cuidados de Suporte em Oncologia (AICSO), Portugal; Centro Hospitalar Vila Nova de Gaia, Espinho, Portugal., Silva J; Associação de Investigação de Cuidados de Suporte em Oncologia (AICSO), Portugal; Centro Hospitalar Vila Nova de Gaia, Espinho, Portugal., Hjermstad MJ; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital and Institute of Clinical Medicine of University of Oslo, Oslo, Norway; Regional Advisory Unit for Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway., Purkart TU; Department of Neurology and Neuroradiology, Vascular and Interventional Radiology, Medical University of Graz, Austria., Seidel C; Department of Radiation Oncology, University of Leipzig Medical Center, Leipzig, Germany., Talhi N; Department of Radiation Oncology, University of Leipzig Medical Center, Leipzig, Germany., Pichler J; Institut für Innere Medizin mit Neuroonkologie, Kepler Universitätsklinikum GmbH, Linz, Austria., Höllmüller I; Institut für Innere Medizin mit Neuroonkologie, Kepler Universitätsklinikum GmbH, Linz, Austria., Brown L; John Eastwood Hospice, Sutton-in-Ashfield, United Kingdom., Hand M; John Eastwood Hospice, Sutton-in-Ashfield, United Kingdom., Klein M; Cancer Center Amsterdam, Brain Tumor Center, Amsterdam, the Netherlands; Department of Medical Psychology, Amsterdam University Medical Centers (Location VUmc), Amsterdam, the Netherlands., Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Uitdehaag BMJ; Department of Neurology & Brain Tumor Center Amsterdam, Amsterdam University Medical Centers (Location VUmc), Amsterdam, the Netherlands., Taphoorn MJB; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: m.j.b.taphoorn@lumc.nl., Dirven L; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov; Vol. 212, pp. 114335. Date of Electronic Publication: 2024 Sep 21.

Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging.

Autor: van Dorth D; C. J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Jiang FY; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Radiology, HagaZiekenhuis, Den Haag, The Netherlands., Schmitz-Abecassis B; C. J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Medical Delta, Delft, The Netherlands., Croese RJI; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Den Haag, The Netherlands., Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Den Haag, The Netherlands., Smits M; Medical Delta, Delft, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Den Haag, The Netherlands., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Den Haag, The Netherlands., de Bresser J; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., van Osch MJP; C. J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Medical Delta, Delft, The Netherlands.

Publikováno v: NMR in biomedicine [NMR Biomed] 2024 Sep; Vol. 37 (9), pp. e5166. Date of Electronic Publication: 2024 Apr 23.

Palliative care services in neuro-oncology: Mind the gap.

Autor: Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Leeper HE; Section of Geriatrics and Palliative Medicine, Department of Medicine, Biological Sciences Division, The University of Chicago, Chicago, Illinois, USA.

Publikováno v: Neuro-oncology practice [Neurooncol Pract] 2024 Aug 06; Vol. 11 (5), pp. 513-514. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).

Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.

Autor: Avila EK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Tobochnik S; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, VA Boston Healthcare System, Boston, Massachusetts, USA., Inati SK; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA., Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., McKhann GM; Department of Neurosurgery, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York, USA., Riviello JJ; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, Texas, USA., Rudà R; Division of Neuro-Oncology, Department of Neuroscience 'Rita Levi Montalcini,' University of Turin, Italy., Schiff D; Department of Neurology, Division of Neuro-Oncology, University of Virginia School of Medicine, Charlottesville, Virginia, USA., Tatum WO; Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA., Templer JW; Department of Neurology, Northwestern University, Chicago, Illinois, USA., Weller M; Department of Neurology, Clinical Neuroscience Centre, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Center, and Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Publikováno v: Neuro-oncology [Neuro Oncol] 2024 Jan 05; Vol. 26 (1), pp. 7-24.

MRI phenotypes of glioblastomas early after treatment are suggestive of overall patient survival.

Autor: Schmitz-Abecassis B; C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Medical Delta, South-Holland, The Netherlands., Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., Jiang J; Department of Radiology, HagaZiekenhuis, The Hague, The Netherlands., Keller JA; C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Croese RJI; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., van Dorth D; C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Ghaznawi R; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands., Kant IMJ; Clinical Artificial Intelligence Implementation and Research Lab (CAIRELab) and Department of Information Technology & Digital Innovation, Leiden University Medical Center, Leiden, The Netherlands.; Department of Digital Health, University Medical Center Utrecht, Utrecht, The Netherlands., Taphoorn MJB; C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., van Osch MJP; Medical Delta, South-Holland, The Netherlands., Koekkoek JAF; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands., de Bresser J; C.J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2023 Oct 12; Vol. 5 (1), pp. vdad133. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).